Yang T, Zou M, Xie Y, Zhang Y, Wang K, Jiang S
Cell Div. 2024; 19(1):35.
PMID: 39719623
PMC: 11669227.
DOI: 10.1186/s13008-024-00140-y.
Fischer J, Erkner E, Radszuweit P, Hentrich T, Keppeler H, Korkmaz F
Int J Mol Sci. 2024; 25(23).
PMID: 39684470
PMC: 11641557.
DOI: 10.3390/ijms252312760.
Chen Y, Kilic E, Wang E, Rossman W, Suzuki A
bioRxiv. 2024; .
PMID: 39677682
PMC: 11643120.
DOI: 10.1101/2024.12.05.627000.
Klemm C, Olafsson G, Wood H, Mellor C, Zabet N, Thorpe P
Nucleus. 2024; 15(1):2420129.
PMID: 39618027
PMC: 11622623.
DOI: 10.1080/19491034.2024.2420129.
Wang Z, Lan J, Feng Y, Chen Y, Chen M
Eur Biophys J. 2024; 54(1-2):33-43.
PMID: 39611994
DOI: 10.1007/s00249-024-01729-5.
Sterile Alpha Motif Domain-Containing 5 Suppresses Malignant Phenotypes and Tumor Growth in Breast Cancer: Regulation of Polo-Like Kinase 1 and c-Myc Signaling in a Xenograft Model.
Tuo Y, Ye Y
Cureus. 2024; 16(11):e73259.
PMID: 39524172
PMC: 11550111.
DOI: 10.7759/cureus.73259.
Rational Design of HER2-Targeted Combination Therapies to Reverse Drug Resistance in Fibroblast-Protected HER2+ Breast Cancer Cells.
Poskus M, McDonald J, Laird M, Li R, Norcoss K, Zervantonakis I
Cell Mol Bioeng. 2024; 17(5):491-506.
PMID: 39513002
PMC: 11538110.
DOI: 10.1007/s12195-024-00823-0.
From Crypts to Cancer: A Holistic Perspective on Colorectal Carcinogenesis and Therapeutic Strategies.
Gharib E, Robichaud G
Int J Mol Sci. 2024; 25(17).
PMID: 39273409
PMC: 11395697.
DOI: 10.3390/ijms25179463.
Advances in the understanding of nuclear pore complexes in human diseases.
Li Y, Zhu J, Zhai F, Kong L, Li H, Jin X
J Cancer Res Clin Oncol. 2024; 150(7):374.
PMID: 39080077
PMC: 11289042.
DOI: 10.1007/s00432-024-05881-5.
Research Advances of Lipid Nanoparticles in the Treatment of Colorectal Cancer.
Zhang J, Ali K, Wang J
Int J Nanomedicine. 2024; 19:6693-6715.
PMID: 38979534
PMC: 11229238.
DOI: 10.2147/IJN.S466490.
PP2A-B56 regulates Mid1 protein levels for proper cytokinesis in fission yeast.
Chrupcala M, Moseley J
bioRxiv. 2024; .
PMID: 38979265
PMC: 11230426.
DOI: 10.1101/2024.06.28.601230.
CDCA5 accelerates progression of breast cancer by promoting the binding of E2F1 and FOXM1.
Xiong Y, Shi L, Li L, Yang W, Zhang H, Zhao X
J Transl Med. 2024; 22(1):639.
PMID: 38978058
PMC: 11232132.
DOI: 10.1186/s12967-024-05443-w.
Elevating PLK1 overcomes BETi resistance in prostate cancer via triggering BRD4 phosphorylation-dependent degradation in mitosis.
Zhang Y, Fong K, Mao F, Wang R, Allison D, Napier D
Cell Rep. 2024; 43(7):114431.
PMID: 38968071
PMC: 11334074.
DOI: 10.1016/j.celrep.2024.114431.
Genome-Wide Gene-Environment Interaction Analysis Identifies Novel Candidate Variants for Growth Traits in Beef Cattle.
Deng T, Li K, Du L, Liang M, Qian L, Xue Q
Animals (Basel). 2024; 14(11).
PMID: 38891742
PMC: 11171348.
DOI: 10.3390/ani14111695.
Identification of a novel prognostic signature based on vitamin metabolism clustering-related genes in lung adenocarcinoma.
Chen Y, Jiang Y, Li X, Huang H, Zhou Y, Zhang C
Transl Lung Cancer Res. 2024; 13(5):1084-1100.
PMID: 38854940
PMC: 11157371.
DOI: 10.21037/tlcr-24-245.
PLK1 inhibition leads to mitotic arrest and triggers apoptosis in cholangiocarcinoma cells.
Moolmuang B, Chaisaingmongkol J, Singhirunnusorn P, Ruchirawat M
Oncol Lett. 2024; 28(1):316.
PMID: 38807667
PMC: 11130613.
DOI: 10.3892/ol.2024.14449.
Overexpression of PLK1 Molecule Following Incomplete Thermal Ablation Promotes the Proliferation and Invasion of Residual Hepatocellular Carcinoma.
Kang T, Chen J, Wan W, Pang J, Wen R, Bai X
Mol Biotechnol. 2024; .
PMID: 38782874
DOI: 10.1007/s12033-024-01181-y.
Proteomic Analysis of Domestic Cat Blastocysts and Their Secretome Produced in an In Vitro Culture System without the Presence of the Zona Pellucida.
Veraguas-Davila D, Zapata-Rojas C, Aguilera C, Saez-Ruiz D, Saravia F, Castro F
Int J Mol Sci. 2024; 25(8).
PMID: 38673927
PMC: 11050229.
DOI: 10.3390/ijms25084343.
PLK1 and FoxM1 expressions positively correlate in papillary thyroid carcinoma and their combined inhibition results in synergistic anti-tumor effects.
Poyil P, Siraj A, Padmaja D, Parvathareddy S, Thangavel S, Alobaisi K
Mol Oncol. 2024; 18(3):691-706.
PMID: 38361222
PMC: 10920088.
DOI: 10.1002/1878-0261.13610.
Phosphorylation-dependent deubiquitinase OTUD3 regulates YY1 stability and promotes colorectal cancer progression.
Wu L, Zhou Z, Yu Y, Cheng C, Zhou S, Yan Y
Cell Death Dis. 2024; 15(2):137.
PMID: 38351178
PMC: 10864350.
DOI: 10.1038/s41419-024-06526-8.
